Google_site External News
Regulatory & Compliance Articles
Google News – FDA (biotech/pharma) External News
UPDATED: Replimune secures FDA approval for melanoma therapy Tudriqev after long regulatory battle - fiercepharma.com
Google News – FDA (biotech/pharma) External News
Rumors of biggest pharma merger ever drop amid Q2 earnings, contentious FDA adcomms - BioSpace
Google News – Biopharma External News
EXCLUSIVE: Sunshine Biopharma Targets Canadian Market with New Women's Health Drug Approval - Yahoo Finance
Google News – Pharmaceuticals External News
Arrowhead Pharmaceuticals Acquires FDA Priority Review Voucher - Arrowhead Pharmaceuticals, Inc.
Google News – Digital Health External News
FDA’s Draft MDUFA VI Commitment Letter: What It Means for AI and Digital Health - Bipartisan Policy Center
Google News – Oncology External News
Jazz to withdraw Zepzelca with FDA in second-line small cell lung cancer - Fierce Pharma
Google News – FDA (biotech/pharma) External News
What does FDA's proposed DTC advertising rule mean for pharma? - pharmaphorum
Google News – EMA (biotech/pharma) External News
Polpharma Biologics gains FDA and EMA review acceptances - PharmaTimes
Google News – FDA (biotech/pharma) External News
Biotech leaders call for streamlining of INDs as FDA’s TrialBlazer rolls out - BioSpace
Google News – EMA (biotech/pharma) External News
Sun Pharma Partner Philogen Resubmits EMA Application for Melanoma Therapy Nidlegy - Medical Dialogues
Google News – EMA (biotech/pharma) External News
Polpharma Biologics’ Entyvio biosimilar accepted for FDA, EMA review - The Pharma Letter
Google News – EMA (biotech/pharma) External News
Polpharma and Fresenius Kabi's Vedolizumab Biosimilar PB016 Clears FDA, EMA Review Acceptance - BioPharm International
Google News – EMA (biotech/pharma) External News
EU pharma regulators publish annual AI observatory report - Osborne Clarke
Google News – EMA (biotech/pharma) External News